Article info
PDFLetter
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
- Correspondence to Dr I E van der Horst-Bruinsma, VU University Medical Centre, Rheumatology Department, room 3A-64, P O Box 7057, 1007 MB Amsterdam, The Netherlands; ie.vanderhorst{at}vumc.nl
Citation
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
Publication history
- Accepted February 7, 2009
- First published October 12, 2009.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.